Full text
PDFPage 476
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Browne M. K., Leslie G. B., Pfirrmann R. W. Taurolin, a new chemotherapeutic agent. J Appl Bacteriol. 1976 Dec;41(3):363–368. doi: 10.1111/j.1365-2672.1976.tb00647.x. [DOI] [PubMed] [Google Scholar]
- Browne M. K. The treatment of peritonitis by an antiseptic - taurolin. Pharmatherapeutica. 1981;2(8):517–522. [PubMed] [Google Scholar]
- McCormick J. B., Getchell J. P., Mitchell S. W., Hicks D. R. Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet. 1984 Dec 15;2(8416):1367–1369. doi: 10.1016/s0140-6736(84)92060-9. [DOI] [PubMed] [Google Scholar]
- Mitsuya H., Popovic M., Yarchoan R., Matsushita S., Gallo R. C., Broder S. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science. 1984 Oct 12;226(4671):172–174. doi: 10.1126/science.6091268. [DOI] [PubMed] [Google Scholar]
- Myers E., Allwood M. C., Gidley M. J., Sanders J. K. The relationship between structure and activity of taurolin. J Appl Bacteriol. 1980 Feb;48(1):89–96. doi: 10.1111/j.1365-2672.1980.tb05210.x. [DOI] [PubMed] [Google Scholar]
- Pfirrmann R. W., Leslie G. B. The anti-endotoxin activity of Taurolin in experimental animals. J Appl Bacteriol. 1979 Feb;46(1):97–102. doi: 10.1111/j.1365-2672.1979.tb02586.x. [DOI] [PubMed] [Google Scholar]
- Rozenbaum W., Dormont D., Spire B., Vilmer E., Gentilini M., Griscelli C., Montagnier L., Barre-Sinoussi F., Chermann J. C. Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet. 1985 Feb 23;1(8426):450–451. doi: 10.1016/s0140-6736(85)91162-6. [DOI] [PubMed] [Google Scholar]
- Spire B., Barré-Sinoussi F., Montagnier L., Chermann J. C. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet. 1984 Oct 20;2(8408):899–901. doi: 10.1016/s0140-6736(84)90657-3. [DOI] [PubMed] [Google Scholar]